Health Care/Hospital
Coronavirus (2019-nCoV): The Facts
Collaboration Leads the Way to Better Understanding of Pathogen SAN FRANCISCO, Feb.1, 2020 /PRNewswire/ -- Author: Barry Bunin, PhD, CEO of Collaborative Drug Discovery, Inc. Originally published on https://www.collaborativedrug.com/coronavirus-2019-ncov-facts/ As news about the Wuhan Corona...
BSI 2020 Chinese New Year Holiday Office Reschedule Statement
BEIJING, Jan. 29, 2020 /PRNewswire/ -- According to the official statement issued by the State Council's General Office on the extension of the Spring Festival holiday in 2020, which is aimed to strengthen the prevention and control of the new type of corona virus infection with pneumonia, effect...
Honeywell Donates US $1 Million in Equipment to Support Fight Against Coronavirus in Wuhan
SHANGHAI, Jan. 31, 2020 /PRNewswire/ -- Honeywell today announced that it will donate US$1 million worth of equipment to support hospitals in Wuhan in their fight against the coronavirus outbreak. The donation includes technologies such as air and water purification systems; ICU air management so...
Coronavirus: New Gear Offers Protection For Patients And Healthcare Workers
MIAMI, Jan. 31, 2020 /PRNewswire/ -- In the ongoing war against Coronavirus, a new technology can provide much-needed protection and benefits for patients and healthcare workers.Radiation Shield Technologies' Demron Chemical Biological Radiological and Nuclear suits have patented thermal conducti...
The Antimicrobial Crisis: New Antibiotics Could Avert 230,000 Deaths Per Year
Recent clinical studies presented at International Symposium organized by Fondazione Internazionale Menarini The World Health Organization warns: invest more and invest now in research to avoid catastrophic consequences for public health FLORENCE, Italy, Jan. 30, 2020 /PRNewswire/ -- The introdu...
Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China
Agreement will facilitate clinical trial translations in China PLYMOUTH MEETING, Pa., Jan. 30, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development inChina of INO-4800, Inovio'...
Alma, A Sisram Medical Company, Launches Breakthrough ClearSkin PRO: Doubling the Power of Previous Solutions, Providing Visibly Younger Looking Skin
NURNBERG, Germany, Jan. 30, 2020 /PRNewswire/ -- Alma, one of the top five
global leaders of energy-based medical and aesthetics solutions, today
announced launch ofClearSkin PRO
ERBA Mannheim Poised to Be Game Changer in Total Lab Automation at Medlab Middle East 2020
10 New launches at MEDLAB ME exhibition positions Erba as a complete end-to-end
provider.
LONDON, Jan. 30, 2020 /PRNewswire/ -- Erba Mannheim
Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell's Gene Editing Platform and Oncology Product Portfolio
CAMBRIDGE, England and MILPITAS, Calif., Jan. 30, 2020 /PRNewswire/ -- Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce the asset purchase of the gene editing platform and oncology product portfolio of Applied StemCell, Inc. (ASC) for life science res...
Consent Judgment Reached for Case Involving Improprieties of Q & M Dental's Subsidiaries in Johor Bahru
JOHOR BAHRU, Malaysia, Jan. 30, 2020 /PRNewswire/ -- A full and final settlement of all claims had been reached between Q & M Dental Group (Singapore ) Limited, Q & M Dental Group (Malaysia) Sdn Bhd, Q & M Dental Surgery (Molek) Sdn Bhd & Q & M Dental Surgery (Austin) Sdn Bhd ("the Q & M Compan...
Melco announces HK$20 million donation to support and accelerate measures to contain the spread of the new strain of coronavirus
MACAU, Jan. 30, 2020 /PRNewswire/ -- In light of the serious public health concerns associated with the new strain of coronavirus outbreak, Melco announced today it is working with the Government to donateHK$20 million to support initiatives for Melco. The donation will be used to purchase medica...
Proya sets up US$2.2 million charitable public fund to fully support 2019-nCoV epidemic prevention and control
HANGZHOU, China, Jan. 29, 2020 /PRNewswire/ -- In line with the firm's corporate mission of delivering a "Beautiful and Better Life", Proya Cosmetics Co., Ltd. (SHA: 603605) is contributing to the effort to control and prevent further expansion of the 2019 novel Coronavirus (2019-nCoV) epidemic ...
Infinitus donates 6 million yuan in cash and supplies to support prevention and treatment efforts in dealing with 2019-nCoV
GUANGZHOU, China, Jan. 29, 2020 /PRNewswire/ -- In the last few days, all attention inChina is focused on the prevention and treatment of the pneumonia caused by the novel coronavirus (2019-nCoV). Medical staff from both Wuhan and around the country, as well as people from all walks of life, are ...
Innovation Zed and A. Menarini Diagnostics Enter Commercial Agreement for InsulCheck Connect
FLORENCE, Italy and DUBLIN, Jan. 29, 2020 /PRNewswire/ -- Innovation Zed, developer of novel Insulin Pen "InsulCheck Connect" add-on device, and A. Menarini Diagnostics, a leading diagnostics company, today announced a partnership to commercialize the InsulCheck Connect device developed by Innov...
XJTLU Researcher Adding Piece To Puzzle Of New Coronavirus
SUZHOU, JIANGSU, China, Jan. 29, 2020 /PRNewswire/ -- According to a researcher at Xi'an Jiaotong-Liverpool University, the Wuhan coronavirus, nCoV-2019, is closely related to SARS from the viewpoint of virus evolution. "Our findings suggest the nCoV-2019 lineage is related to the bat coronavir...
ZTE helps China Telecom realize China's first 5G remote diagnosis of new coronavirus pneumonia
SHENZHEN, China, Jan. 29, 2020 /PRNewswire/ -- ZTE Corporation (0763.HK/000063,SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, andSichuan Branch of China Telecom today have realizedChina's first 5G remote diagnosis ...
WuXi Biologics Provides Operation Update Related to the Coronavirus Outbreak
SHANGHAI, Jan. 29, 2020 /PRNewswire/ -- The coronavirus outbreak is having a potentially significant social and economic impact inChina. WuXi Biologics is closely monitoring the coronavirus outbreak and is complying with guidance from the relevant authorities. Our management team is working vigil...
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
SHANGHAI, Jan. 29, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its efforts in enabling the development of multipl...
MiRXES collaborates with NUS and DxD Hub to move Singapore to the forefront of global microRNA research and application
SINGAPORE, Jan. 29, 2020 /PRNewswire/ -- MiRXES, a leading Singaporean biotech start-up in microRNA[1] (miRNA) technology and diagnostics, collaborated with NUS and DxD Hub to mark the tenth year of miRNA research and clinical translation inSingapore. These organizations jointly led a non-coding ...
Havas Health & You Network Expands Global Innovation Offering
NEW YORK, Jan. 29, 2020 /PRNewswire/ -- Announcing today, Havas Health & You
(HH&Y) has appointedPhilippe Huot-Louradour to the newly created position of
European Technology & Innovation Lead andDavid Hunt to Global Chief Digital
Officer, adding to his role as CEO of HH&Y West.
Week's Top Stories
Most Reposted
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
[Picked up by 309 media titles]
2024-12-20 16:25AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
[Picked up by 306 media titles]
2024-12-20 18:11XTransfer and OCBC Jointly Announce Comprehensive Partnership
[Picked up by 266 media titles]
2024-12-23 17:36CKGSB Successfully Hosts 2024 MBA Professor Training Program for Western China
[Picked up by 252 media titles]
2024-12-24 00:06ebm-papst A&NZ Achieves Complete Operational Carbon Neutrality in appropriate Scope 1,2 and 3 criterion in 2023
[Picked up by 244 media titles]
2024-12-25 15:45